ArticleBMC cardiovascular disorders2026
Association of MTHFR and platelet-related blood cell ratio parameters with ischemic stroke in Gansu population.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo investigate the association of MTHFR polymorphisms with the susceptibility to ischemic stroke (IS) in Gansu population in China, and the predictive value of platelet-related ratios for the risk of IS in different genotypes.
methodsWe enrolled 121 IS patients admitted between June and December 2022 and 121 recruited from the same source population healthy controls. Clinical data were collected, and peripheral blood was analyzed for routine parameters. Genotyping for MTHFR C677T and A1298C was performed using PCR fluorescence probe. Statistical analysis was conducted with SPSS Statistics 27.0.
resultsIn the Gansu population, the MTHFR C677T TT and A1298C CC genotypes were significantly associated with increased IS risk (P = 0.005, P = 0.01). Specific combined genotypes at these loci (CT/CC, TT/AC, TT/CC) elevated IS risk by 1.4-, 1.7- and 1.4-fold, respectively. In the IS group, the MPV/PLT, MPV/LY and RDW/PLT ratios were significantly elevated, while PLT/NE was lower (all P < 0.05). Additionally, patients with the MTHFR C677T TT genotype had higher NE levels than those with the CC genotype (P = 0.028), and those with the MTHFR A1298C CC genotype exhibited a higher MPV/LY ratio than AA carriers (P = 0.038). ROC analysis indicated that combining NE and MPV/LY for IS risk assessment yielded an AUC of 0.784 (95% CI: 0.726-0.842).
conclusionMTHFR C677T and A1298C polymorphisms are associated with IS risk in the Gansu population. The combined assessment of NE, MPV/LY, and MTHFR C677T genotyping may offer adjunctive information for IS risk assessment, pending independent validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.